Genuine Parts Company vs Kenvue

Side-by-side comparison of AI visibility scores, market position, and capabilities

Kenvue leads in AI visibility (94 vs 83)
Genuine Parts Company logo

Genuine Parts Company

LeaderConsumer Retail

Enterprise

Atlanta automotive and industrial distribution (NYSE: GPC) ~$23.5B FY2024 revenue; NAPA Auto Parts 6,100+ stores, Motion Industries MRO, EV transition adaptation competing with AutoZone and O'Reilly.

AI VisibilityBeta
Overall Score
A83
Category Rank
#100 of 290
AI Consensus
69%
Trend
stable
Per Platform
ChatGPT
78
Perplexity
80
Gemini
91

About

Genuine Parts Company is an Atlanta, Georgia-based distribution company — publicly traded on the New York Stock Exchange (NYSE: GPC) as an S&P 500 Consumer Discretionary component — distributing automotive replacement parts, industrial parts and supplies, and electrical/electronic materials through approximately 60,000 employees across four segments: Automotive Parts Group (NAPA Auto Parts brand in North America — 6,100+ company-owned and independent NAPA stores, 500+ NAPA Auto Care service centers), EIS (electrical/electronic wire, connectors, and insulation materials distribution), S.P. Richards (office products distribution — sold in 2019), and Motion Industries (industrial parts and MRO distribution — motion control, hydraulic components, power transmission equipment for manufacturing customers). In fiscal year 2024, Genuine Parts reported revenues of approximately $23.5 billion (+2% organic growth), with the Automotive segment generating approximately $13.7 billion and the Industrial segment (Motion Industries) generating approximately $8.9 billion, as the company navigated softness in both automotive aftermarket (new vehicle sales higher, reducing older vehicle repair frequency) and industrial MRO (manufacturing activity slowing in some sectors). CEO Will Stengel (joined as CEO in 2023, previously COO) leads GPC's strategy of accelerating the value-added service model: NAPA Auto Care (where NAPA acts as the preferred parts supplier to a network of independent auto repair shops) ties the repair shop customer to NAPA through commercial account pricing, parts return programs, and customer lead generation — creating commercial fleet account relationships rather than commodity transaction-based distribution. The EV parts transition (electric vehicle brake pad reduction — less regenerative braking wear — and absence of oil changes, spark plugs, and transmission fluid service) creates a long-term product mix challenge for automotive aftermarket distributors that GPC is addressing through EV-specific parts category expansion (EV charging components, high-voltage battery service training, EV-specific lubricants and fluids).

Full profile
Kenvue logo

Kenvue

LeaderConsumer Goods

Enterprise

Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.

AI VisibilityBeta
Overall Score
A94
Category Rank
#31 of 290
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
91
Perplexity
99
Gemini
89

About

Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).

Full profile

AI Visibility Head-to-Head

83
Overall Score
94
#100
Category Rank
#31
69
AI Consensus
70
stable
Trend
stable
78
ChatGPT
91
80
Perplexity
99
91
Gemini
89
86
Claude
93
85
Grok
86

Key Details

Category
Enterprise
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.